Each year, nearly 90,000 people in the United States are diagnosed with Parkinson's disease. This figure represents a significant increase from previous estimates, which were around 60,000 diagnoses annually. Globally, more than 10 million people are living with Parkinson's disease. These statistics highlight the growing prevalence of this neurodegenerative disorder, which is the second most common after Alzheimer's disease.
Understanding these statistics is crucial for planning healthcare resources and supporting ongoing research efforts to combat Parkinson's disease.
Research has shown that the incidence of Parkinson's disease varies significantly across different regions and populations. Understanding these variations is crucial for healthcare planning and resource allocation.
The study of Parkinson's disease incidence is a well-researched area, with numerous studies conducted globally to understand its epidemiology. The incidence rates are often reported per 100,000 person-years, and these rates can vary based on factors such as age, gender, and ethnicity. Recent research highlights the increasing prevalence of Parkinson's disease, particularly in high-income countries, due to factors like aging populations and improved diagnostic capabilities12.
Global Incidence Rates:
Regional Variations:
Local Studies:
Environmental and Genetic Factors:
Data Limitations:
Impact of Healthcare Access:
Overall, while there is a wealth of research on Parkinson's disease incidence, variations in data quality and regional differences highlight the need for continued study and international collaboration to better understand and address this growing health concern.
Research
This paper investigates the epidemiology of Parkinson's disease, highlighting variations in prevalence and incidence across different demographics and regions. The study emphasizes the role of genetic and environmental factors in the disease's development and the need for comprehensive prevention strategies.
Key findings include the observation that Parkinson's disease is more common in older individuals and men, with potential environmental factors like neurotoxic agents contributing to its prevalence. The study also notes ethnic differences in disease risk, possibly due to healthcare access disparities.
For those living with or caring for someone with Parkinson's disease, this research underscores the importance of understanding the multifactorial causes of the disease, which can inform prevention and management strategies.
The paper is published in a reputable journal, Lancet, and provides a thorough analysis of Parkinson's disease epidemiology, making it a reliable source for understanding the disease's global impact.
January 2024 • Lancet (London, England)
Research
This cohort study examines the incidence of Parkinson's disease in the UK from 2006 to 2016, using a large primary care database. The study aims to determine if the incidence has changed over time, accounting for age and diagnostic patterns.
The key finding is that the incidence of Parkinson's disease remained stable during the study period, suggesting no major changes in underlying risk factors. The incidence rate was approximately 144 per 100,000 person-years in 2016.
For individuals affected by Parkinson's disease, this study provides reassurance that the incidence has not increased, indicating stable risk factors over the decade.
The study is published in NPJ Parkinson's disease, a specialized journal, and uses robust data from a large UK database, making it a reliable source for understanding Parkinson's disease trends in the UK.
March 2022 • NPJ Parkinson's disease
Each year, approximately 60,000 people are diagnosed with Parkinson's disease in the United States. This statistic highlights Parkinson's as one of the most common brain diseases, second only to Alzheimer's1. The incidence of Parkinson's disease varies globally, with factors such as aging populations and environmental exposures contributing to the number of new cases23.
Global Trends
These insights underscore the importance of understanding the factors influencing Parkinson's disease diagnosis rates and the need for updated statistics to reflect these changes.
Video
Dr. Rachel Dolhun from The Michael J. Fox Foundation explains that in the United States, approximately 60,000 people are diagnosed with Parkinson's disease each year. This statistic highlights Parkinson's as one of the most common brain diseases, second only to Alzheimer's. The average age of diagnosis is 60, and the risk increases with age.
August 2017 • The Michael J. Fox Foundation for Parkinson's Research
Video
Hugh Johnston discusses the changing statistics of Parkinson's disease, noting that the incidence rates vary by country. He highlights that the aging population contributes to the increasing number of cases, and that younger onset Parkinson's disease (YOPD) is often underreported. The webinar emphasizes the need for updated statistics to reflect these changes.
April 2020 • Cure Parkinson's
Was this helpful?
This is not healthcare advice or a recommendation. This tool is in beta and currently experimental. It is designed to help you find the most recent and helpful sources, from different voices, for you to take to consider with your healthcare team.
We appreciate any feedback as we aim to help speed up breakthroughs for all conditions.
© 2026 Turnto